Celiac Disease Market, By Treatment, By Disease Type, By Distribution Channel, By Route of Administration, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Celiac Disease Market size was valued at US$ 967.83 Million in 2025, expanding at a CAGR of 10.34% from 2026 to 2033.

Celiac disease is a long-term autoimmune digestive disorder where the body reacts abnormally to gluten found in wheat, barley, and rye. Gluten intake damages the small intestine, reducing nutrient absorption. Symptoms include abdominal pain, diarrhoea, fatigue, anaemia, and weight loss. It is managed through a strict gluten-free diet and monitoring.

The celiac disease market focuses on diagnosis, treatment, and management of gluten-related autoimmune digestive disorder affecting the small intestine. From a global perspective, the celiac disease market is gaining attention due to rising diagnosis rates and stronger public health initiatives. However, as mentioned by government agencies and health institutions such as the WHO and NIH, a significant number of cases go undetected because the symptoms are similar to other gastrointestinal diseases. Nations like India, Italy, and Canada are also raising their levels of consciousness on screening with national programs for gastroenterology and food safety guidelines. This increasing focus on early detection, combined with expanding availability of gluten-free food standards and diagnostic technologies, is shaping steady development in the celiac disease healthcare ecosystem worldwide.

Celiac Disease Market- Market Dynamics

Rising Awareness Regarding Gluten-Related Digestive Disorders Supporting Earlier Diagnosis

Rising awareness regarding gluten-related digestive disorders is playing an important role in supporting earlier diagnosis of Celiac disease. As people become more informed about symptoms such as fatigue, abdominal discomfort, and nutrient deficiencies, they are more likely to seek medical testing at an early stage. This has improved the use of blood screening tests and biopsy procedures in clinical practice, helping doctors identify the condition before severe intestinal damage occurs.

Health agencies within governments, such as the U.S. National Institutes of Health (NIH), stress the importance of recognizing the need for awareness, as many cases go unnoticed owing to the overlapping symptoms with other digestive illnesses. Agencies such as the World Health Organization also promote awareness among patients and doctors on diseases related to autoimmunity and diet for the benefit of digestive health on a global scale. Such efforts have led to the development of diagnostic tools and advice on gluten-free diets.

Celiac Disease Market- Segmentation Analysis:

The Global Celiac Disease Market is segmented on the basis of Treatment, Disease Type, Distribution Channel, Route of Administration, End User, and Region.

Under the route of administration, the market is divided into two types. Among these, oral formulations are expected to contribute significantly, as they are convenient for long-term dietary and therapeutic management. Individuals managing autoimmune digestive disorders often favor easy-to-consume treatment options and nutritional supplements that can be incorporated into daily routines without clinical assistance. Research organizations and healthcare providers are also increasing focus on oral investigational therapies intended to improve intestinal health and reduce gluten-triggered immune reactions. Companies such as Takeda Pharmaceutical Company and Anokion SA are involved in clinical research activities associated with oral celiac disease therapies and immune tolerance approaches. In addition, expanding availability of oral gluten-free nutritional products and supplements is encouraging broader acceptance of non-invasive management approaches among patients and healthcare providers.

In terms of diseases, the market is segmented into Classical Celiac Disease, Non-Classical Celiac Disease, Silent Celiac Disease, Refractory Celiac Disease, and Potential Celiac Disease. Among these, classical celiac disease maintains a strong position, as patients commonly experience noticeable digestive symptoms such as chronic diarrhoea, abdominal discomfort, weight loss, and nutrient absorption difficulties. These visible symptoms often encourage earlier physician consultation and diagnostic testing compared with less symptomatic forms of the condition. Healthcare organizations are also increasing awareness regarding gastrointestinal autoimmune disorders to support timely identification and dietary management. The National Institutes of Health stated that untreated celiac disease may result in nutritional deficiencies and intestinal complications, encouraging a stronger diagnostic focus. Firms like Thermo Fisher Scientific and Bio-Rad Laboratories are extending their diagnostic testing capabilities concerning autoimmune digestive diseases. Increased recognition of digestive wellness and gluten reactions is aiding the involvement of doctors in managing traditional celiac disease cases.

Celiac Disease Market- Geographical Insights

Across the Asia Pacific region, healthcare systems are gradually strengthening awareness, diagnosis, and nutritional management practices associated with celiac disease, creating supportive conditions for continued progress in the market. Governments and healthcare organizations within this region are encouraging food labeling transparency, digestive disorder screening, and broader availability of gluten-free nutritional products to improve patient care. Research published in Scientific Reports indicated that celiac disease prevalence in several Asia Pacific countries is increasingly recognized through improved clinical testing and public health awareness programs. In the above area, India has an organized health and food regulatory system through measures taken by the Food Safety and Standards Authority of India (FSSAI) that put forward regulations concerning gluten-free foods labeling and claim standardization in order to assist people with gluten intolerance.

Government-supported healthcare awareness programs and expanding gastroenterology services are also encouraging earlier disease identification and dietary counseling support. Organizations like Nestle Health Science, Takeda Pharmaceutical Company, and Dr. Schar, which function under such conditions, are increasingly becoming involved with gluten-free nutrition, products for gastroenterological healthcare, as well as experimental therapies for autoimmune diseases that affect the digestive tract. Such a confluence of healthcare regulatory policy, medical science, nutritional product research, and industry participation is leading to effective management of celiac disease in the healthcare landscape of the Asia Pacific region.

Japan Celiac Disease Market- Country Insights

Japan is gradually increasing healthcare awareness related to celiac disease and gluten-sensitive digestive conditions through food labeling guidance, nutritional monitoring, and specialty dietary support initiatives. Japanese authorities and food safety organizations are encouraging accurate allergen labeling and safer food manufacturing practices to support individuals requiring gluten-restricted diets. Another initiative by the government is to develop standards for non-gluten rice flour products in order to enhance food labeling and export quality. Some organizations that have partnered with the government include Nestle Health Science and SGS Japan, which are contributing towards gluten-free nutrition and certification programs. In addition, Japan is experiencing an increase in involvement from various industries that are focused on improving access to food for people with celiac disease. Food labeling practices that involve government supervision for packaged foods have increased the transparency of ingredient labeling and consumer safety. There is knowledge spreading on the advantages and significance of eating gluten-free foods, which increasing with health education programs and nutritional counseling is provided by healthcare providers. This is assisting in celiac disease awareness in Japan.

Celiac Disease Market- Competitive Landscape:

The celiac disease market is shaped by the participation of pharmaceutical companies, nutrition providers, diagnostic organizations, and biotechnology firms focusing on autoimmune digestive disorder management and gluten-related health conditions. The activities within industries are affected by ongoing developments in nutritional products that are free of gluten, investigational drugs, diagnostics, and immunotherapy treatments for the purposes of improving patient care and the long-term dietary treatment. Some of the companies that are establishing their presence in the health sector through research and nutrition products include Takeda Pharmaceutical Company, Nestle Health Science, Anokion SA, Barinthus Biotherapeutics, and EVAXION Biotech. In 2025, Takeda continued the development of investigational therapies associated with gluten-triggered immune responses, while Anokion expanded clinical evaluation programs for KAN-101 to support antigen-specific immune tolerance research. Continuous attention toward digestive health awareness, gluten sensitivity diagnosis, and dietary support solutions is encouraging broader healthcare engagement and treatment advancement within the celiac disease field.

Recent Developments:

In November 2025, 9 Meters Biopharma continued research activities associated with larazotide acetate, an investigational therapy intended to support intestinal barrier function in celiac disease patients. The program contributed to ongoing efforts toward alternative therapeutic management approaches beyond gluten-free diets.

In August 2025, Dr. Schar introduced additional gluten-free food products developed for consumers managing celiac disease-related dietary restrictions. The expansion supported the wider availability of specialized nutritional options in international food markets.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELIAC DISEASE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
Pfizer Inc.
Sanofi
Novartis AG
Amgen Inc.
Anokion SA
Barinthus Biotherapeutics
Topas Therapeutics GmbH
Entero Therapeutics, Inc.
Equillium, Inc.
Chugai Pharmaceutical Co., Ltd.
Immunic Therapeutics
Mozart Therapeutics Australia Pty Ltd
AMYRA Biotech AG
Calypso Biotech
Forte Biosciences, Inc.
Hoffmann-La Roche Ltd.
Parvus Therapeutics
BioLineRx Ltd.
Glenmark Pharmaceuticals Ltd.
Hikma Pharmaceuticals PLC
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Nestle Health Science
Others

GLOBAL CELIAC DISEASE MARKET, BY TREATMENT - MARKET ANALYSIS, 2020 - 2033

Infliximab
Larazotide Acetate
Clinical Trial Phase Products
Oral Capsule Formulation
Adult Celiac Patients
Pediatric Investigational Use
Monotherapy and Combination Therapy
Gluten Free Diet
Packaged Gluten-Free Foods
Gluten-Free Bakery Products
Gluten-Free Snacks
Gluten-Free Nutritional Supplements
Gluten-Free Beverages
Others
Corticosteroids
Immunosuppressive Drugs
Enzyme Therapies
Monoclonal Antibodies
Probiotics and Microbiome Modulators

GLOBAL CELIAC DISEASE MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2020 - 2033

Classical Celiac Disease
Non-Classical Celiac Disease
Silent Celiac Disease
Refractory Celiac Disease
Potential Celiac Disease

GLOBAL CELIAC DISEASE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others

GLOBAL CELIAC DISEASE MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033

Oral
Parenteral

GLOBAL CELIAC DISEASE MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

Hospitals
Homecare
Others

GLOBAL CELIAC DISEASE MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6523

1. Celiac Disease Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Celiac Disease Market Snippet by Treatment
- 2.1.2. Celiac Disease Market Snippet by Disease Type
- 2.1.3. Celiac Disease Market Snippet by Distribution Channel
- 2.1.4. Celiac Disease Market Snippet by Route of Administration
- 2.1.5. Celiac Disease Market Snippet by End User
- 2.1.6. Celiac Disease Market Snippet by Country
- 2.1.7. Celiac Disease Market Snippet by Region
2.2. Competitive Insights

3. Celiac Disease Key Market Trends

3.1. Celiac Disease Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Celiac Disease Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Celiac Disease Market Opportunities
3.4. Celiac Disease Market Future Trends

4. Celiac Disease Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Celiac Disease Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Celiac Disease Market Landscape

6.1. Celiac Disease Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Celiac Disease Market - By Disease Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Disease Type, 2025 & 2033 (%)
- 7.1.2. Classical Celiac Disease
- 7.1.3. Non-Classical Celiac Disease
- 7.1.4. Silent Celiac Disease
- 7.1.5. Refractory Celiac Disease
- 7.1.6. Potential Celiac Disease

8. Celiac Disease Market - By Distribution Channel

8.1. Overview
- 8.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
- 8.1.2. Hospital Pharmacy
- 8.1.3. Online Pharmacy
- 8.1.4. Retail Pharmacy
- 8.1.5. Others

9. Celiac Disease Market - By Treatment

9.1. Overview
- 9.1.1. Segment Share Analysis, By Treatment, 2025 & 2033 (%)
- 9.1.2. Infliximab
- 9.1.3. Larazotide Acetate
  - 9.1.3.1. Clinical Trial Phase Products
  - 9.1.3.2. Oral Capsule Formulation
  - 9.1.3.3. Adult Celiac Patients
  - 9.1.3.4. Pediatric Investigational Use
  - 9.1.3.5. Monotherapy and Combination Therapy
- 9.1.4. Gluten Free Diet
  - 9.1.4.1. Packaged Gluten-Free Foods
  - 9.1.4.2. Gluten-Free Bakery Products
  - 9.1.4.3. Gluten-Free Snacks
  - 9.1.4.4. Gluten-Free Nutritional Supplements
  - 9.1.4.5. Gluten-Free Beverages
- 9.1.5. Others
  - 9.1.5.1. Corticosteroids
  - 9.1.5.2. Immunosuppressive Drugs
  - 9.1.5.3. Enzyme Therapies
  - 9.1.5.4. Monoclonal Antibodies

10. Celiac Disease Market - By Route of Administration

10.1. Overview
- 10.1.1. Segment Share Analysis, By Disease Type, 2025 & 2033 (%)
- 10.1.2. Oral
- 10.1.3. Parenteral

11. Celiac Disease Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 11.1.2. Hospitals
- 11.1.3. Homecare
- 11.1.4. Others

12. Celiac Disease Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Celiac Disease Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Celiac Disease Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.18. Denmark
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Denmark Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Denmark Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.19. Rest of Europe
  - 12.3.19.1. Overview
  - 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.19.3. Rest of the Europe Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.3.19.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.3.19.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.19.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Celiac Disease Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.17. Taiwan
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Taiwan Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Taiwan Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.18. Vietnam
  - 12.4.18.1. Overview
  - 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.18.3. Vietnam Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.18.4. Vietnam Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.18.5. Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.18.6. Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.19. Rest of APAC
  - 12.4.19.1. Overview
  - 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.19.3. Rest of APAC Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.4.19.4. Rest of APAC Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.4.19.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.19.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Celiac Disease Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Celiac Disease Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.15. Iran
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Iran Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Iran Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Iran Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.16. Qatar
  - 12.6.16.1. Overview
  - 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.16.3. Qatar Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.6.16.4. Qatar Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.6.16.5. Qatar Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.16.6. Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.17. Rest of MEA
  - 12.6.17.1. Overview
  - 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.17.3. Rest of MEA Market Size and Forecast, By Treatment, 2020 - 2033 (US$ Million)
  - 12.6.17.4. Rest of MEA Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
  - 12.6.17.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.17.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Celiac Disease Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Takeda Pharmaceutical Company Limited
- 13.2.2. Teva Pharmaceutical Industries Ltd.
- 13.2.3. Pfizer Inc.
- 13.2.4. Sanofi
- 13.2.5. Novartis AG
- 13.2.6. Amgen Inc.
- 13.2.7. Anokion SA
- 13.2.8. Barinthus Biotherapeutics
- 13.2.9. Topas Therapeutics GmbH
- 13.2.10. Entero Therapeutics, Inc.
- 13.2.11. Equillium, Inc.
- 13.2.12. Chugai Pharmaceutical Co., Ltd.
- 13.2.13. Immunic Therapeutics
- 13.2.14. Mozart Therapeutics Australia Pty Ltd
- 13.2.15. AMYRA Biotech AG
- 13.2.16. Calypso Biotech
- 13.2.17. Forte Biosciences, Inc.
- 13.2.18. Hoffmann-La Roche Ltd.
- 13.2.19. Parvus Therapeutics
- 13.2.20. BioLineRx Ltd.
- 13.2.21. Glenmark Pharmaceuticals Ltd.
- 13.2.22. Hikma Pharmaceuticals PLC
- 13.2.23. Thermo Fisher Scientific Inc.
- 13.2.24. Bio-Rad Laboratories, Inc.
- 13.2.25. Nestle Health Science
- 13.2.26. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us